Differences in Healthcare Utilization and Associated Costs Between Patients Prescribed vs. Nonprescribed Opioids During an Inpatient or Emergency Department Visit
dc.contributor.author | Xie, Lin | en_US |
dc.contributor.author | Joshi, Ashish V. | en_US |
dc.contributor.author | Schaaf, David | en_US |
dc.contributor.author | Mardekian, Jack | en_US |
dc.contributor.author | Harnett, James | en_US |
dc.contributor.author | Shah, Nilay D. | en_US |
dc.contributor.author | Baser, Onur | en_US |
dc.date.accessioned | 2014-06-04T14:57:06Z | |
dc.date.available | WITHHELD_13_MONTHS | en_US |
dc.date.available | 2014-06-04T14:57:06Z | |
dc.date.issued | 2014-06 | en_US |
dc.identifier.citation | Xie, Lin; Joshi, Ashish V.; Schaaf, David; Mardekian, Jack; Harnett, James; Shah, Nilay D.; Baser, Onur (2014). "Differences in Healthcare Utilization and Associated Costs Between Patients Prescribed vs. Nonprescribed Opioids During an Inpatient or Emergency Department Visit." Pain Practice 14(5): 446-456. | en_US |
dc.identifier.issn | 1530-7085 | en_US |
dc.identifier.issn | 1533-2500 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/107375 | |
dc.description.abstract | Objectives Compare healthcare resource utilization ( HCRU ) and costs between patients prescribed opioids ( R x OP ) and those who were not ( N o R x OP ) during an emergency department ( ED ) or inpatient visit. Methods Retrospective cohort analysis was performed ( J anuary 2006 to S eptember 2010). Continuously eligible R x OP patients in ED /inpatient settings ( J anuary 2007 to S eptember 2009) were included if age was ≥ 12 years by initial prescription date (or random date between first ED /inpatient admission and S eptember 30, 2009 [ N oRx OP patients]). Healthcare resource utilization and costs for 12 months after initial prescription were compared. Univariate descriptive analyses were performed for baseline and outcome variables and compared using appropriate tests. Risk adjustment compared HCRU between R x OP and N o R x OP cohorts for the postindex period. Results Of 27,599 eligible patients, R x OP patients ( n = 18,819) were younger, less likely to be male, more likely to reside in southern U nited S tates and to have Preferred Provider Organization health plans, and had lower comorbidity index scores, compared with N o R x OP patients ( n = 8,780). R x OP patients were less likely to have nonpain‐related comorbidities and more frequently diagnosed with pain‐related comorbidities. Unmatched and propensity‐matched R x OP patients experienced higher HCRU and costs in all subcategories (total, inpatient, outpatient ED , physician, pharmacy, other outpatient settings). Opioid abuse frequency was low in patients with common diagnoses/procedures within 3 months before initial prescription (0.48%). Average time to abuse was < 1 year (201 days). Conclusion Most patients were prescribed opioids initially during ED /inpatient visits and incurred higher HCRU than those not prescribed opioids. Among those with diagnosed opioid abuse after initiating opioids, time to diagnosis was rapid (range: 14 to 260 days) for patients with common diseases and procedures. | en_US |
dc.publisher | Substance Abuse and Mental Health Services Administration | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Opioid‐Related Disorders | en_US |
dc.subject.other | Healthcare Costs | en_US |
dc.subject.other | Healthcare Utilization | en_US |
dc.subject.other | Opioid Abuse | en_US |
dc.subject.other | Opioids | en_US |
dc.title | Differences in Healthcare Utilization and Associated Costs Between Patients Prescribed vs. Nonprescribed Opioids During an Inpatient or Emergency Department Visit | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/107375/1/papr12098.pdf | |
dc.identifier.doi | 10.1111/papr.12098 | en_US |
dc.identifier.source | Pain Practice | en_US |
dc.identifier.citedreference | The Joint Commission, Sentinel Event Alert. Safe Use of Opioids in Hospitals. 49; 2012. http://www.jointcommission.org/assets/1/18/SEA_49_opioids_8_2_12_final.pdf (accessed October 8, 2012). | en_US |
dc.identifier.citedreference | Bell K, Salmon A. Pain, physical dependence, and pseudo‐addiction: redefining addiction for “nice” people. Int J Drug Policy. 2009; 20: 170 – 178. | en_US |
dc.identifier.citedreference | Kuehn BM. Opioid prescriptions soar. JAMA. 2007; 297: 249 – 251. | en_US |
dc.identifier.citedreference | Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006; 81: 103 – 107. | en_US |
dc.identifier.citedreference | Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of national findings (Office of Applied Studies, NSDUH Series H‐38A, HHS Publication No. SMA 10‐4856). Rockville, MD: Substance Abuse and Mental Health Services Administration; 2010. | en_US |
dc.identifier.citedreference | Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. CDC Grant Rounds: Prescription Drug Overdoses—A U.S. Epidemic; 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6101a3.htm (accessed November 12, 2012). | en_US |
dc.identifier.citedreference | Department of Justice. Drug Enforcement Administration. Office of Diversion Control. Automation of Reports and Consolidated Orders System (ARCOS); 1996–2006: http://www.deadiversion.usdoj.gov/arcos/retrail_drug_summary/2006/06_rpt4.pdf (accessed July 26, 2012). | en_US |
dc.identifier.citedreference | Trescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic non‐cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician. 2008; 11 ( 2 suppl ): S5 – S62. | en_US |
dc.identifier.citedreference | White AG, Birnbaum HG, Mareva MN, et al. Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm. 2005; 11: 469 – 479. | en_US |
dc.identifier.citedreference | O'Connor PG, Samet JH. Substance abuse. J Gen Intern Med. 2002; 17: 334 – 340. | en_US |
dc.identifier.citedreference | National Center for Health Statistics. Medication Therapy in Ambulatory Medical Care: United State, 2003–04. Vital and Health Statistics, Series 13, number 63, December, 2006. http://www.cdc.gov/hcha/data/series/ar_13/ar13_163.pdf#page=26 (accessed July 26, 2012). | en_US |
dc.identifier.citedreference | Couto JE, Romney MC, Leider HL, Sharma S, Goldfarb NI. High rates of inappropriate drug use in the chronic pain population. Popul Health Manag. 2009; 12: 185 – 190. | en_US |
dc.identifier.citedreference | Centers for Disease Control and Prevention (CDC). Emergency department visits involving nonmedical use of selected prescription drugs—United States, 2004–2008. MMWR Morb Mortal Wkly Rep. 2010; 59: 705 – 709. | en_US |
dc.identifier.citedreference | Olsen Y, Daumit GL, Ford GE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain. 2006; 7: 225 – 235. | en_US |
dc.identifier.citedreference | Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998; 36: 8 – 27. | en_US |
dc.identifier.citedreference | Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008; 61: 1234 – 1240. | en_US |
dc.identifier.citedreference | Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992; 45: 197 – 203. | en_US |
dc.identifier.citedreference | Emptage NP, Strum R, Robinson RL. Depression and comorbid pain as predictors of disability, employment, insurance status, and health care costs. Psychiatr Serv. 2005; 56: 468 – 474. | en_US |
dc.identifier.citedreference | Becker A, Held H, Redaelli M, et al. Low back pain in primary care: costs of care and prediction of future health care utilizations. Spine. 2010; 35: 1714 – 1720. | en_US |
dc.identifier.citedreference | McDonald DC, Carlson K, Izrael D. Geographic variation in opioid prescribing in the U.S. J Pain. 2012; 13: 988 – 996. | en_US |
dc.identifier.citedreference | Reid MC, Engles‐Horton LL, Weber MAB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002; 17: 173 – 179. | en_US |
dc.identifier.citedreference | Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: the TROUP study. Pain. 2010; 150: 332 – 339. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.